J2360 HCPCS code: Injection, orphenadrine citrate, up to 60 mg
J2360 is the HCPCS Level II code for injection, orphenadrine citrate, up to 60 mg. In 2024 Medicare paid an average of $6.29 per service for J2360 across 5,782 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 50% from 2022 to 2024 (11,641 to 5,782 services). In 2024, about 1,235 clinicians billed Medicare for J2360 for 3,619 beneficiaries; Florida, Alabama, Mississippi accounted for 44% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J2360 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,235 |
| Medicare beneficiaries | 3,619 |
| States with claims | 35 |
| Share of services in top 3 states (Florida, Alabama, Mississippi) | 44% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2360, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 11,641 | 6,230 | $4.36 | $3.17 |
| 2023 | 7,306 | 4,629 | $6.43 | $4.75 |
| 2024 | 5,782 | 3,619 | $8.74 | $6.29 |
States with the most J2360 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,241 | $6.81 |
| Alabama | 893 | $5.94 |
| Mississippi | 374 | $6.40 |
| Texas | 349 | $6.03 |
| California | 342 | $6.57 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Prescribing Information |
| practitioner claims | 2 | Prescribing Information |
What changed for J2360
- 1982-01-01: J2360 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2360?
J2360 is the HCPCS Level II code for injection, orphenadrine citrate, up to 60 mg. Short descriptor: "Orphenadrine injection".
How much does Medicare pay for J2360?
In 2024, the average Medicare payment was $6.29 per service (average allowed $8.74).
Does Medicare cover J2360?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J2360 can be billed per day?
3 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2305 — Injection, nitroglycerin, 5 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2360
- Watch J2360 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2360
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.